Miranda Mitchell, MD
Internal Medicine · Baton Rouge, LANPI 1700045770
Payments from drug & device makers
Across 72 payments — averaging $22.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$235
- Chiesi USA, Inc.$138
- Emmaus Medical, Inc.$134
- Global Blood Therapeutics, Inc.$123
- Merck$95
- Stemline Therapeutics Inc.$89
- plus $773 from 22 others
What the payments were for
- Food & beverage$1,587100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 11 | $235 |
| Chiesi USA, Inc. | 8 | $138 |
| Emmaus Medical, Inc. | 7 | $134 |
| Global Blood Therapeutics, Inc. | 1 | $123 |
| Merck | 4 | $95 |
| Stemline Therapeutics Inc. | 5 | $89 |
| Johnson & Johnson(2 entities) | 4 | $81 |
| Ipsen Biopharmaceuticals, Inc | 3 | $76 |
| Pfizer | 2 | $69 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $66 |
| Karyopharm Therapeutics Inc. | 3 | $62 |
| Incyte Corporation | 3 | $56 |
| AVEO Pharmaceuticals, Inc. | 2 | $46 |
| Amgen | 2 | $36 |
| Abbott | 1 | $32 |
| Exelixis Inc. | 1 | $24 |
| Eisai Inc. | 1 | $24 |
| Taiho Oncology, Inc. | 1 | $24 |
| Daiichi Sankyo Inc. | 1 | $21 |
| Bayer | 1 | $20 |
| Sanofi | 1 | $20 |
| EMD Serono, Inc. | 1 | $20 |
| G1 Therapeutics, Inc. | 1 | $18 |
| Morphosys, US Inc. | 1 | $18 |
| Gilead | 1 | $17 |
| Exact Sciences | 1 | $17 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $15 |
| Boehringer Ingelheim | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OXBRYTA$123
How this compares
$1,587 in reported general payments places this provider in the 70th percentile of 1,528 internal medicine providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Morphine Sulfate ErMorphine Sulfate | 228 | $6,115 |
| Fentanyl | 39 | $5,820 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 260 | $4,344 |
| Oxycodone Hcl | 235 | $2,523 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 80 | $1,253 |
| Hydroxyurea | 36 | $1,040 |
| Promethazine Hcl | 16 | $121 |
| Gabapentin | 14 | $119 |
| Morphine Sulfate | 17 | $79 |
| Hydromorphone Hcl | 26 | $55 |
| Tramadol Hcl | 18 | $49 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Baton Rouge
- Katherine PearceBaton Rouge$12M
- Donna RyanBaton Rouge$991K
- Gertrude Chimeka AnyanwokeBaton Rouge$611K
- Deepesh PatelBaton Rouge$304K
- John SchwabBaton Rouge$122K
- Barret MurphyBaton Rouge$43K
- Brian GremillionBaton Rouge$27K
- Raoul ManalacBaton Rouge$27K
- Bradley MeekBaton Rouge$20K
- William SmithNew Orleans$50.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.